Harold Collard, MD

Associate Vice Chancellor, Clinical Research
Director, CTSI
Medicine
+1 415 514-8884

Dr. Collard is Associate Vice Chancellor of Clinical Research and Professor in Residence in the Division of Pulmonary and Critical Care Medicine, Department of Medicine at UCSF, Director of the UCSF Clinical and Translational Science Institute (CTSI), and Director of the UCSF Interstitial Lung Disease Program. Over the last 15 years, Dr. Collard has produced seminal articles on the epidemiology, natural history, and management of interstitial lung diseases, and he is an internationally recognized clinical researcher and trialist. He has had extensive experience designing and leading both NIH-funded and industry-sponsored clinical trials, from small, single center pharmacokinetic studies to large multicenter registration studies. Dr. Collard has trained over a dozen clinical and translational research fellows (he is a recipient of a K24 award in patient-oriented research) who are now leading academic research programs in lung fibrosis around the world. As Associate Vice Chancellor of Clinical Research and Director of the UCSF CTSI, Dr. Collard is responsible for providing clinical researcher faculty, staff and trainees with institutional support and resources to enable their work.

Dr. Collard earned a medical degree at Duke University. He completed an internship, residency and chief residency in internal medicine at UCSF as well as a fellowship in pulmonary and critical care medicine at the University of Colorado. In addition to his administrative work and research activities, Dr. Collard sees patients with interstitial lung disease as part of the UCSF Interstitial Lung Disease Clinic (http://www.ucsfhealth.org/ild).

Research Interests

Dr. Collard is a clinical and translational researcher focused on patients and populations of patients with interstitial lung disease. Dr. Collard is currently conducting projects investigating: (1) acute exacerbations of idiopathic pulmonary fibrosis (acute events that cause significant worsening of disease for many patients); (2) predicting disease progression, and; (3) clinical trials of promising but unproven therapies for patients with interstitial lung disease.

Publications: 

A systematically derived exposure assessment instrument for Chronic Hypersensitivity Pneumonitis.

Chest

Barnes H, Morisset J, Molyneaux P, Westall G, Glaspole I, Collard HR

Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.

Respirology (Carlton, Vic.)

Farrand E, Vittinghoff E, Ley B, Butte AJ, Collard HR

Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes.

Scientific reports

Casanova N, Zhou T, Gonzalez-Garay ML, Rosas IO, Goldberg HJ, Ryter SW, Collard HR, El-Chemaly S, Flaherty KR, Hunninghake GM, Lasky JA, Lederer DJ, Machado RF, Martinez FJ, Noth I, Raghu G, Choi AMK, Garcia JGN

Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity.

American journal of respiratory and critical care medicine

Richeldi L, Cottin V, Brown KK, Flaherty KR, Johannson KA, Travis WD, Collard HR

Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.

The Lancet. Respiratory medicine

Nathan SD, Behr J, Collard HR, Cottin V, Hoeper MM, Martinez FJ, Corte TJ, Keogh AM, Leuchte H, Mogulkoc N, Ulrich S, Wuyts WA, Yao Z, Boateng F, Wells AU

Resequencing Study Confirms Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine

Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Soon Kim D, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Montes Worboys A, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstrong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA

Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients with Idiopathic Pulmonary Fibrosis.

Chest

Liu GY, Ventura IB, Achtar-Zadeh N, Elicker BM, Jones KD, Wolters PJ, Collard HR, Adegunsoye A, Strek ME, Ley B

Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!

The European respiratory journal

Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C

Closing the Evidence Gap in Interstitial Lung Disease: The Promise of Real World Data.

American journal of respiratory and critical care medicine

Farrand E, Anstrom KJ, Bernard G, Butte AJ, Iribarren C, Ley B, Martinez F, Collard HR

Significance of bronchiolocentric fibrosis in patients with histopathologic usual interstitial pneumonia.

Histopathology

Tanizawa K, Ley B, Vittinghoff E, Elicker BM, Henry TS, Wolters PJ, Brownell R, Liu S, Collard HR, Jones KD

The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicenter observational study.

The European respiratory journal

Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

American journal of respiratory and critical care medicine

Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC

Response.

Chest

Johannson KA, Vittinghoff E, Morisset J, Wolters PJ, Noth EM, Balmes JR, Collard HR

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.

The Lancet. Respiratory medicine

Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters PJ, Yates R, Anstrom KJ, Collard HR

Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-Analysis.

Annals of the American Thoracic Society

Guler SA, Ellison K, Algamdi M, Collard HR, Ryerson CJ

Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials.

The Lancet. Respiratory medicine

Neighbors M, Cabanski CR, Ramalingam TR, Sheng XR, Tew GW, Gu C, Jia G, Peng K, Ray JM, Ley B, Wolters PJ, Collard HR, Arron JR

Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.

The Lancet. Respiratory medicine

Dressen A, Abbas AR, Cabanski C, Reeder J, Ramalingam TR, Neighbors M, Bhangale TR, Brauer MJ, Hunkapiller J, Reeder J, Mukhyala K, Cuenco K, Tom J, Cowgill A, Vogel J, Forrest WF, Collard HR, Wolters PJ, Kropski JA, Lancaster LH, Blackwell TS, Arron JR, Yaspan BL

Reply to Moodley: A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease.

American journal of respiratory and critical care medicine

Ryerson CJ, Walsh SLF, Collard HR

Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey.

American journal of respiratory and critical care medicine

Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR, Walsh SLF, Ley B

A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

American journal of respiratory and critical care medicine

Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, Behr J, Cottin V, Danoff SK, Flaherty KR, Lederer DJ, Lynch DA, Martinez FJ, Raghu G, Travis WD, Udwadia Z, Wells AU, Collard HR

Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine

Cottin V, Hansell DM, Sverzellati N, Weycker D, Antoniou KM, Atwood M, Oster G, Kirchgaessler KU, Collard HR, Wells AU

A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.

Chest

Rosas IO, Goldberg HJ, Collard HR, El-Chemaly S, Flaherty K, Hunninghake GM, Lasky JA, Lederer DJ, Machado R, Martinez FJ, Maurer R, Teller D, Noth I, Peters E, Raghu G, Garcia JGN, Choi AMK

Idiopathic pulmonary fibrosis.

Nature reviews. Disease primers

Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, Swigris JJ, Taniguchi H, Wells AU

Rebuttal From Drs Mooney and Collard.

Chest

Mooney JJ, Collard HR

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.

BMJ open respiratory research

Flaherty KR, Brown KK, Wells AU, Clerisme-Beaty E, Collard HR, Cottin V, Devaraj A, Inoue Y, Le Maulf F, Richeldi L, Schmidt H, Walsh S, Mezzanotte W, Schlenker-Herceg R

Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine

Ley B, Swigris J, Day BM, Stauffer JL, Raimundo K, Chou W, Collard HR

Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis.

The European respiratory journal

Johannson KA, Vittinghoff E, Morisset J, Lee JS, Balmes JR, Collard HR

The Hospitalized Patient with Interstitial Lung Disease: A Hospitalist Primer.

Journal of hospital medicine

Farrand E, Shah R, Collard H

Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model.

Chest

Morisset J, Vittinghoff E, Elicker BM, Hu X, Le S, Ryu JH, Jones KD, Haemel A, Golden JA, Boin F, Ley B, Wolters PJ, King TE, Collard HR, Lee JS

Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement.

Annals of the American Thoracic Society

Ley B, Urbania T, Husson G, Vittinghoff E, Brush DR, Eisner MD, Iribarren C, Collard HR

Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis.

The European respiratory journal

Collard HR, Richeldi L, Kim DS, Taniguchi H, Tschoepe I, Luisetti M, Roman J, Tino G, Schlenker-Herceg R, Hallmann C, du Bois RM

The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.

Respiratory medicine

Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE, Kim DS, Collard HR, Lee JS

Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.

Respiratory medicine

Natalini JG, Swigris JJ, Morisset J, Elicker BM, Jones KD, Fischer A, Collard HR, Lee JS

Idiopathic pulmonary fibrosis.

Lancet (London, England)

Richeldi L, Collard HR, Jones MG

CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis.

Thorax

Jia G, Chandriani S, Abbas AR, DePianto DJ, N'Diaye EN, Yaylaoglu MB, Moore HM, Peng I, DeVoss J, Collard HR, Wolters PJ, Egen JG, Arron JR

Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity Pneumonitis.

Chest

Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson KA, Assayag D, Lee J, Wolters PJ, Collard HR, Koth LL

Reply: Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine

Corte TJ, Ryerson CJ, Collard HR

Reply: The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air.

American journal of respiratory and critical care medicine

Ryerson CJ, Corte TJ, Martinez FJ, Collard HR

The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.

Thorax

Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE, Wolters PJ, Collard HR, Ley B

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.

The Lancet. Respiratory medicine

Raghu G, Brown KK, Collard HR, Cottin V, Gibson KF, Kaner RJ, Lederer DJ, Martinez FJ, Noble PW, Song JW, Wells AU, Whelan TP, Wuyts W, Moreau E, Patterson SD, Smith V, Bayly S, Chien JW, Gong Q, Zhang JJ, O'Riordan TG

The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.

The Lancet. Respiratory medicine

Martinez FJ, Chisholm A, Collard HR, Flaherty KR, Myers J, Raghu G, Walsh SL, White ES, Richeldi L

Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?

Respiratory medicine

Nathan SD, Behr J, Cottin V, Collard HR, Hoeper MM, Martinez FJ, Wells AU

Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.

Chest

Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, Fell CD, Manganas H, Dubé BP, Wolters PJ, Collard HR, Ryerson CJ, Ley B

A new era in idiopathic interstitial pneumonias: Epilogue to a review series.

Respirology (Carlton, Vic.)

Corte TJ, Collard H, Wells AU

Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine

Ley B, Bradford WZ, Vittinghoff E, Weycker D, du Bois RM, Collard HR

Hispanics/Latinos With Type 2 Diabetes Have Functional and Symptomatic Pulmonary Impairment Mirroring Kidney Microangiopathy: Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Diabetes care

Klein OL, Aviles-Santa L, Cai J, Collard HR, Kanaya AM, Kaplan RC, Kinney GL, Mendes E, Smith L, Talavera G, Wu D, Daviglus M

Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.

The European respiratory journal

Newton CA, Batra K, Torrealba J, Kozlitina J, Glazer CS, Aravena C, Meyer K, Raghu G, Collard HR, Garcia CK

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.

American journal of respiratory and critical care medicine

Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, Behr J, Brown KK, Cottin V, Flaherty KR, Fukuoka J, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kolb M, Lynch DA, Myers JL, Raghu G, Richeldi L, Taniguchi H, Martinez FJ

The Unmet Educational Needs of Patients with Interstitial Lung Disease. Setting the Stage for Tailored Pulmonary Rehabilitation.

Annals of the American Thoracic Society

Morisset J, Dubé BP, Garvey C, Bourbeau J, Collard HR, Swigris JJ, Lee JS

miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis.

PloS one

Disayabutr S, Kim EK, Cha SI, Green G, Naikawadi RP, Jones KD, Golden JA, Schroeder A, Matthay MA, Kukreja J, Erle DJ, Collard HR, Wolters PJ

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia.

BMC genetics

Fingerlin TE, Zhang W, Yang IV, Ainsworth HC, Russell PH, Blumhagen RZ, Schwarz MI, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch DA, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Murphy E, Smith K, McKean D, Pedersen BS, Talbert J, Powers J, Markin CR, Beckman KB, Lathrop M, Freed B, Langefeld CD, Schwartz DA

Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine

Brownell R, Kaminski N, Woodruff PG, Bradford WZ, Richeldi L, Martinez FJ, Collard HR

A diagnostic model for chronic hypersensitivity pneumonitis.

Thorax

Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Wolters PJ, Collard HR

Acetylcysteine in IPF: the knockout blow?

The Lancet. Respiratory medicine

Wijsenbeek MS, Collard HR

Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.

The European respiratory journal

Raghu G, Chen SY, Hou Q, Yeh WS, Collard HR

Management of Myositis-Related Interstitial Lung Disease.

Chest

Morisset J, Johnson C, Rich E, Collard HR, Lee JS

Multidisciplinary Approach to Hypersensitivity Pneumonitis.

Journal of thoracic imaging

Elicker BM, Jones KD, Henry TS, Collard HR

Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes.

Scientific reports

Withana NP, Ma X, McGuire HM, Verdoes M, van der Linden WA, Ofori LO, Zhang R, Li H, Sanman LE, Wei K, Yao S, Wu P, Li F, Huang H, Xu Z, Wolters PJ, Rosen GD, Collard HR, Zhu Z, Cheng Z, Bogyo M

Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.

American journal of respiratory and critical care medicine

Costabel U, Inoue Y, Richeldi L, Collard HR, Tschoepe I, Stowasser S, Azuma A

Gastroesophageal Reflux in Idiopathic Pulmonary Fibrosis: More than a Gut Feeling?

Respiration; international review of thoracic diseases

Wuyts WA, Collard HR

Idiopathic pulmonary fibrosis: continuing to make progress.

The Lancet. Respiratory medicine

Lee JS, Collard HR

House of Cards? Testing Fundamental Assumptions in Idiopathic Pulmonary Fibrosis Epidemiology.

American journal of respiratory and critical care medicine

Ley B, Collard HR

Reply: Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?

American journal of respiratory and critical care medicine

Richeldi L, Le Maulf F, Schlenker-Herceg R, Collard HR

The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes.

Chest

Andrade J, Schwarz M, Collard HR, Gentry-Bumpass T, Colby T, Lynch D, Kaner RJ

Interstitial lung diseases in the hospitalized patient.

BMC medicine

Disayabutr S, Calfee CS, Collard HR, Wolters PJ

Models of disease behavior in idiopathic pulmonary fibrosis.

BMC medicine

Johannson KA, Ley B, Collard HR

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?

European respiratory review : an official journal of the European Respiratory Society

Harari S, Humbert M, Blasi F, Collard HR, Matucci-Cerinic M, Simonneau G, Vancheri C, Wells AU, Cottin V

Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria.

Respiratory medicine

Assayag D, Kim EJ, Elicker BM, Jones KD, Golden JA, King TE, Koth LL, Shum AK, Wolters PJ, Collard HR, Lee JS

Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.

The European respiratory journal

Ryerson CJ, Cottin V, Brown KK, Collard HR

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

American journal of respiratory and critical care medicine

Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, Hoogsteden H, Schünemann HJ

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.

The European respiratory journal

Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V

Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.

Annals of the American Thoracic Society

Collard HR, Chen SY, Yeh WS, Li Q, Lee YC, Wang A, Raghu G

The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis.

Respiratory medicine

Assayag D, Vittinghoff E, Ryerson CJ, Cocconcelli E, Tonelli R, Hu X, Elicker BM, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Shum AK, Wolters PJ, Ryu JH, Collard HR

Idiopathic interstitial pneumonias in 2015: A new era.

Respirology (Carlton, Vic.)

Corte TJ, Collard H, Wells AU

A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials.

The European respiratory journal

Collard HR, Bradford WZ, Cottin V, Flaherty KR, King TE, Koch GG, Kolb M, Martinez FJ, Montgomery B, Raghu G, Richeldi L, Rose D, Wells AU, Brown KK

Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.

The Lancet. Respiratory medicine

Durheim MT, Collard HR, Roberts RS, Brown KK, Flaherty KR, King TE, Palmer SM, Raghu G, Snyder LD, Anstrom KJ, Martinez FJ

Nintedanib in the treatment of idiopathic pulmonary fibrosis.

Therapeutic advances in respiratory disease

Mazzei ME, Richeldi L, Collard HR

Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis.

The European respiratory journal

Ley B, Bradford WZ, Weycker D, Vittinghoff E, du Bois RM, Collard HR

Pharmacological treatment of idiopathic pulmonary fibrosis: an update.

Drug discovery today

Spagnolo P, Wells AU, Collard HR

Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis.

Chest

Collard HR, Brown KK, Martinez FJ, Raghu G, Roberts RS, Anstrom KJ

Open-access biorepository for idiopathic pulmonary fibrosis. The way forward.

Annals of the American Thoracic Society

White ES, Brown KK, Collard HR, Conoscenti CS, Cosgrove GP, Flaherty KR, Leff JA, Martinez FJ, Roman J, Rose D, Violette S, Kaminski N

Molecular biomarkers in idiopathic pulmonary fibrosis.

American journal of physiology. Lung cellular and molecular physiology

Ley B, Brown KK, Collard HR

Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.

Thorax

DePianto DJ, Chandriani S, Abbas AR, Jia G, N'Diaye EN, Caplazi P, Kauder SE, Biswas S, Karnik SK, Ha C, Modrusan Z, Matthay MA, Kukreja J, Collard HR, Egen JG, Wolters PJ, Arron JR

Acute exacerbations complicating interstitial lung disease.

Current opinion in pulmonary medicine

Ryerson CJ, Collard HR

A global registry for idiopathic pulmonary fibrosis: the time is now.

The European respiratory journal

Ryerson CJ, Corte TJ, Collard HR, Richeldi L

Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review.

Chest

Winstone TA, Assayag D, Wilcox PG, Dunne JV, Hague CJ, Leipsic J, Collard HR, Ryerson CJ

Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.

The Lancet. Respiratory medicine

Stuart BD, Lee JS, Kozlitina J, Noth I, Devine MS, Glazer CS, Torres F, Kaza V, Girod CE, Jones KD, Elicker BM, Ma SF, Vij R, Collard HR, Wolters PJ, Garcia CK

Idiopathic pulmonary fibrosis: CT and risk of death.

Radiology

Ley B, Elicker BM, Hartman TE, Ryerson CJ, Vittinghoff E, Ryu JH, Lee JS, Jones KD, Richeldi L, King TE, Collard HR

Staging of idiopathic pulmonary fibrosis: past, present and future.

European respiratory review : an official journal of the European Respiratory Society

Kolb M, Collard HR

Endogenously expressed IL-13Ra2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts.

Journal of immunology (Baltimore, Md. : 1950)

Chandriani S, DePianto DJ, N'Diaye EN, Abbas AR, Jackman J, Bevers J, Ramirez-Carrozzi V, Pappu R, Kauder SE, Toy K, Ha C, Modrusan Z, Wu LC, Collard HR, Wolters PJ, Egen JG, Arron JR

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.

The Lancet. Respiratory medicine

Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

The New England journal of medicine

Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR

Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT.

The Lancet. Respiratory medicine

Johannson KA, de Boer K, Wolters PJ, Golden JA, Lee JS, Collard HR

Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis.

Respiratory medicine

Richeldi L, Cottin V, Flaherty KR, Kolb M, Inoue Y, Raghu G, Taniguchi H, Hansell DM, Nicholson AG, Le Maulf F, Stowasser S, Collard HR

Predicting survival across chronic interstitial lung disease: the ILD-GAP model.

Chest

Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE, Collard HR

A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease.

Chest

Doyle TJ, Lee JS, Dellaripa PF, Lederer JA, Matteson EL, Fischer A, Ascherman DP, Glassberg MK, Ryu JH, Danoff SK, Brown KK, Collard HR, Rosas IO

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

American journal of respiratory and critical care medicine

Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty KR, Garcia CK, Hagood JS, Henke CA, Herzog E, Hogaboam CM, Horowitz JC, King TE, Loyd JE, Lawson WE, Marsh CB, Noble PW, Noth I, Sheppard D, Olsson J, Ortiz LA, O'Riordan TG, Oury TD, Raghu G, Roman J, Sime PJ, Sisson TH, Tschumperlin D, Violette SM, Weaver TE, Wells RG, White ES, Kaminski N, Martinez FJ, Wynn TA, Thannickal VJ, Eu JP

Predictors of mortality in rheumatoid arthritis-related interstitial lung disease.

Respirology (Carlton, Vic.)

Assayag D, Lubin M, Lee JS, King TE, Collard HR, Ryerson CJ

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.

Thorax

Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, Pittrow D, Swigris J, Antoniou K, Baughman RP, Castelino FV, Christmann RB, Christopher-Stine L, Collard HR, Cottin V, Danoff S, Highland KB, Hummers L, Shah AA, Kim DS, Lynch DA, Miller FW, Proudman SM, Richeldi L, Ryu JH, Sandorfi N, Sarver C, Wells AU, Strand V, Matteson EL, Brown KK, Seibold JR

Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study.

Respiratory medicine

Ryerson CJ, Cayou C, Topp F, Hilling L, Camp PG, Wilcox PG, Khalil N, Collard HR, Garvey C

Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.

Current respiratory care reports

Johannson K, Collard HR

Epidemiology of idiopathic pulmonary fibrosis.

Clinical epidemiology

Ley B, Collard HR

Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure.

The European respiratory journal

Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, Kim DS, Collard HR

Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern.

Radiology

Assayag D, Elicker BM, Urbania TH, Colby TV, Kang BH, Ryu JH, King TE, Collard HR, Kim DS, Lee JS

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

American journal of respiratory and critical care medicine

Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D

Pathogenesis of idiopathic pulmonary fibrosis.

Annual review of pathology

Wolters PJ, Collard HR, Jones KD

Update on the diagnosis and classification of ILD.

Current opinion in pulmonary medicine

Ryerson CJ, Collard HR

Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis.

Chest

Mooney JJ, Elicker BM, Urbania TH, Agarwal MR, Ryerson CJ, Nguyen MLT, Woodruff PG, Jones KD, Collard HR, King TE, Koth LL

Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.

Respiratory research

Collard HR, Yow E, Richeldi L, Anstrom KJ, Glazer C

Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.

Chest

Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE, Ryu J, Collard HR

Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

The Lancet. Respiratory medicine

Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G

Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.

American journal of respiratory and critical care medicine

Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE, Martinez FJ, Brown KK

Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis.

The European respiratory journal

Richeldi L, Collard HR, du Bois RM, Jenkins G, Kolb M, Maher TM, Raghu G, Vancheri C, Laurent GJ

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.

Annals of internal medicine

Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG

Outcomes in systemic sclerosis-related lung disease after lung transplantation.

Transplantation

Sottile PD, Iturbe D, Katsumoto TR, Connolly MK, Collard HR, Leard LA, Hays S, Golden JA, Hoopes C, Kukreja J, Singer JP

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

Nature genetics

Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch D, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Cogan JD, Mason WR, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Smith K, McKean D, Pedersen BS, Talbert J, Kidd RN, Markin CR, Beckman KB, Lathrop M, Schwarz MI, Schwartz DA

Prevalence and prognosis of unclassifiable interstitial lung disease.

The European respiratory journal

Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR

Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis.

Respiratory medicine

Lee JS, Kim EJ, Lynch KL, Elicker B, Ryerson CJ, Katsumoto TR, Shum AK, Wolters PJ, Cerri S, Richeldi L, Jones KD, King TE, Collard HR

Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis.

Respiratory research

Cha SI, Ryerson CJ, Lee JS, Kukreja J, Barry SS, Jones KD, Elicker BM, Kim DS, Papa FR, Collard HR, Wolters PJ

Clinical year in review IV: HIV, mycobacterial disease, pulmonary hypertension, and interstitial lung disease.

Proceedings of the American Thoracic Society

Collard HR, Morris A, Daley CL, Humbert M, Meyer KC

Idiopathic pulmonary fibrosis.

Seminars in respiratory and critical care medicine

Adkins JM, Collard HR

A multidimensional index and staging system for idiopathic pulmonary fibrosis.

Annals of internal medicine

Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE, Collard HR

Burden of illness in idiopathic pulmonary fibrosis.

Journal of medical economics

Collard HR, Ward AJ, Lanes S, Cortney Hayflinger D, Rosenberg DM, Hunsche E

Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.

American journal of respiratory and critical care medicine

Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE, Martinez FJ, Brown KK

Depression is a common and chronic comorbidity in patients with interstitial lung disease.

Respirology (Carlton, Vic.)

Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR

Reduced lung diffusion capacity in type 2 diabetes is independent of heart failure.

Diabetes research and clinical practice

Klein OL, Jones M, Lee J, Collard HR, Smith LJ

Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis.

Thorax

Richeldi L, Ryerson CJ, Lee JS, Wolters PJ, Koth LL, Ley B, Elicker BM, Jones KD, King TE, Ryu JH, Collard HR

Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.

Histopathology

Cha SI, Chang CS, Kim EK, Lee JW, Matthay MA, Golden JA, Elicker BM, Jones K, Collard HR, Wolters PJ

Interstitial lung diseases. Preface.

Clinics in chest medicine

King TE, Collard HR, Richeldi L

Dyspnea in idiopathic pulmonary fibrosis: a systematic review.

Journal of pain and symptom management

Ryerson CJ, Donesky D, Pantilat SZ, Collard HR

Risk prediction in idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine

Ley B, Collard HR

Comprehensive care of the patient with idiopathic pulmonary fibrosis.

Current opinion in pulmonary medicine

Lee JS, McLaughlin S, Collard HR

Cough predicts prognosis in idiopathic pulmonary fibrosis.

Respirology (Carlton, Vic.)

Ryerson CJ, Abbritti M, Ley B, Elicker BM, Jones KD, Collard HR

Primum non nocere: safety in clinical trials for IPF.

Respirology (Carlton, Vic.)

Lee JS, Collard HR

Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine

Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE, Collard HR

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

American journal of respiratory and critical care medicine

Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ

Viral infection in acute exacerbation of idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine

Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, Song JW, Huh JW, Taniguchi H, Chiu C, Boushey H, Lancaster LH, Wolters PJ, DeRisi J, Ganem D, Collard HR

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine

Ley B, Collard HR, King TE

Depression and functional status are strongly associated with dyspnea in interstitial lung disease.

Chest

Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR

Pulmonary rehabilitation for interstitial lung disease.

Chest

Ryerson CJ, Garvey C, Collard HR

Management of dyspnea in interstitial lung disease.

Current opinion in supportive and palliative care

Ryerson CJ, Collard HR, Pantilat SZ

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.

The New England journal of medicine

Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW

Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.

American journal of physiology. Lung cellular and molecular physiology

Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King TE, Matthay MA, Kim DS

The age of idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine

Collard HR

Does chronic microaspiration cause idiopathic pulmonary fibrosis?

The American journal of medicine

Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM, Golden JA, King TE

Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function.

Lung

Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE

Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Chest

Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA

Silicone injection causing acute pneumonitis: a case series.

Lung

Zamora AC, Collard HR, Barrera L, Mendoza F, Webb WR, Carrillo G

Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response.

Chest

Ferreira A, Garvey C, Connors GL, Hilling L, Rigler J, Farrell S, Cayou C, Shariat C, Collard HR

Dyspnea in interstitial lung disease.

Current opinion in supportive and palliative care

Collard HR, Pantilat SZ

Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease.

Respiratory medicine

Zamora AC, Wolters PJ, Collard HR, Connolly MK, Elicker BM, Webb WR, King TE, Golden JA

A practical guide for clinicians who treat patients with amiodarone: 2007.

Heart rhythm

Goldschlager N, Epstein AE, Naccarelli GV, Olshansky B, Singh B, Collard HR, Murphy E

Acute exacerbations of idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine

Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE, Lasky JA, Loyd JE, Noth I, Olman MA, Raghu G, Roman J, Ryu JH, Zisman DA, Hunninghake GW, Colby TV, Egan JJ, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kondoh Y, Lynch DA, Müller-Quernheim J, Myers JL, Nicholson AG, Selman M, Toews GB, Wells AU, Martinez FJ

Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?

American journal of respiratory and critical care medicine

Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE

In response to Silvestri.

American journal of infection control

Flanders SA, Saint S, Collard HR

Sildenafil improves walk distance in idiopathic pulmonary fibrosis.

Chest

Collard HR, Anstrom KJ, Schwarz MI, Zisman DA

Patient experiences with pulmonary fibrosis.

Respiratory medicine

Collard HR, Tino G, Noble PW, Shreve MA, Michaels M, Carlson B, Schwarz MI

Anticoagulant therapy and idiopathic pulmonary fibrosis.

Chest

Kinder BW, Collard HR, King TE

Classification and natural history of the idiopathic interstitial pneumonias.

Proceedings of the American Thoracic Society

Kim DS, Collard HR, King TE

Current perspectives on the treatment of idiopathic pulmonary fibrosis.

Proceedings of the American Thoracic Society

Walter N, Collard HR, King TE

Nosocomial pneumonia: state of the science.

American journal of infection control

Flanders SA, Collard HR, Saint S

Clinical problem-solving. A perfect storm.

The New England journal of medicine

Janssen WJ, Collard HR, Saint S, Weinberger SE

Clinical and economic consequences of ventilator-associated pneumonia: a systematic review.

Critical care medicine

Safdar N, Dezfulian C, Collard HR, Saint S

Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis.

The American journal of medicine

Dezfulian C, Shojania K, Collard HR, Kim HM, Matthay MA, Saint S

Clinical problem-solving. Why "why" matters.

The New England journal of medicine

Janssen WJ, Dhaliwal G, Collard HR, Saint S

Diffuse alveolar hemorrhage.

Clinics in chest medicine

Collard HR, Schwarz MI

Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.

Chest

Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE, Brown KK

Prognosis in idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine

Thabut G, Fournier M, Collard HR, Brown KK

Clinical problem-solving. Anatomy of a diagnosis.

The New England journal of medicine

Collard HR, Gruber MP, Weinberger SE, Saint S

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine

Collard HR, King TE, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK

Prevention of ventilator-associated pneumonia: an evidence-based systematic review.

Annals of internal medicine

Collard HR, Saint S, Matthay MA

Demystifying idiopathic interstitial pneumonia.

Archives of internal medicine

Collard HR, King TE

Clinical problem-solving. Diagnosis still in question.

The New England journal of medicine

Jha AK, Collard HR, Tierney LM